Patient-reported outcomes regarding the use of complementary and alternative medicine (CAM) in BCR::ABL1-negative myeloproliferative neoplasias
Use of CAM was recorded in the majority of patients with MPN. Higher use of CAM-related measures was reported by women and patients with longer disease duration. Patients should be regularly consulted about the use of CAM, its risks should be considered and pointed out, and safe methods should be recommended.
Authors
- Carl C. Crodel (ORCID: https://orcid.org/0009-0000-2160-1452)
- Markus P. Radsak (ORCID: https://orcid.org/0000-0002-3991-5721)
- Stefanie Jilg (ORCID: https://orcid.org/0000-0003-1774-7605)
- Charlotte Kohnle
- Florian H. Heidel
- Andreas Hochhaus
- Jutta Hübner
- Holger Nückel
Institutions
- Johannes Gutenberg University Mainz (DE)
- TUM Klinikum (DE)
- Medizinische Hochschule Hannover (DE)
- Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie (DE)
- Jena University Hospital (DE)
- Praxis für Humangenetik (DE)
- Technical University of Munich (DE)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1007/s00432-025-06421-5
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00